Poster Awards

CIMT 2023 Poster Awards

Six early-career researchers were chosen by the CIMT poster jury members to receive the 2023 CIMT Poster Awards in six categories:

Cellular Therapy

Fillipe Rosa do Carmo
INSERM / Université Paris Diderot (Paris, France)  

Abstract 118
”Engineering the stromal compartment of solid tumors circumvents resistance to immune checkpoint blockade by sparking anti-tumor immunity”  

Therapeutic Vaccination

Marco Notaro
San Raffaele Hospital (Milan, Italy)  

Abstract 158
”Simultaneous gene-based delivery of tumor antigen and cytokines to liver macrophages unleash a potent immune response against liver metastases“

IMMunomonitoring

Nicola Herold
University Hospital Tübingen (Tübingen, Germany)  

Abstract 48
”High frequencies of peripheral Vδ1 T cells are associated with poor overall survival of melanoma patients undergoing PD-1 blockade and a late-differentiated phenotype”

New targets & New Leads

Seth Anderson
Broad Institute of MIT and Harvard (Cambridge, USA)  

Abstract 175
”Genome-scale in vivo CRISPR screens identify Erap1 as a non-classical MHC-I-dependent immunotherapy target”

Tumor Biology & Interaction with the Immune System

Judit Díaz-Gómez
Vall d'Hebron Institute of Oncology (Barcelona, Spain)  

Abstract 244
”Unravelling tumor-intrinsic resistance mechanisms to T-cell mediated cytotoxicity in pancreatic cancers”

Improving Immunity

Hannah Newnes
The University of Western Australia (Nedlands, Australia)  

Abstract 28
”Manipulating the balance of pro- and anti-inflammatory signals in the tumour microenvironment to enhance cancer control”

We would like to thank Immatics for their generous support of the 2023 Poster Awards.

CIMT 2022 Poster Awards

Seven early-career researchers were chosen by the CIMT poster jury members to receive the 2022 CIMT Poster Awards in six categories:

Cellular Therapy

Miranda H. Meeuwsen
Leiden University Medical Center, Netherlands 

Abstract 119 
“T cell receptor-based targeting of immunoglobulin constant domains for treatment of Multiple Myeloma” 

‍Therapeutic Vaccination

Ida Olsson
Uppsala University/Strike Pharma, Sweden
‍and
‍Aman Mebrahtu
KTH Royal Institute of Technology Stockholm/Strike Pharma, Sweden

Abstract 31
“An agonistic CD40 bispecific antibody designed for flexible synthetic peptide-cargo delivery through an affinity interaction, a way to ensure optimal T cell activation”

New Targets and New Leads

Marit van Elsas
Leiden University Medical Center, Netherlands

Abstract 77
“CD163 tissue-resident macrophages drive primary and secondary cancer immunotherapy resistance”

 
Immunomonitoring

Simone Blaess
University of Tübingen/Werner Siemens Imaging Center, Germany

Abstract 79 
“In vivo T cell activation kinetics visualized by longitudinal OX40- and CD69-immunoPET during combination cancer immunotherapy” 

‍

Tumor Biology & Interaction with the Immune System

Christian Schmidl  
Leibniz Institute for Immunotherapy, Germany

Abstract #171 
“Integrated single-cell profiling dissects cell-state-specific enhancer landscapes of human tumor infiltrating T cells”

Improving Immunity

Matthieu Besneux 
Prokarium, United Kingdom 

Abstract 182
“ZH9: a live bacterial immunotherapy that reprograms suppressive macrophages and induces trained immunity” 

We would like to thank Immatics for their generous support of the 2022 Poster Awards.

CIMT 2021 eTalk Awards

At the virtual CIMT Annual Meeting in 2021, CIMT honored seven early-career researchers for outstanding eTalk presentations. We would like to thank Immatics for supporting the 2021 eTalk Awards.

Cellular Therapy
Leonie Rosenberger
Charité-Universitätsmedizin
Abstract #137

Watch the presentation:
Mutation-specific T cell receptors from tumor-bearing hosts display optimal functionality

Therapeutic Vaccination
Alejandro Hernandez-Sanchez
German Cancer Research Center-DKFZ
Abstract #32

Watch the presentation:
Immunogenicity and HLA binding affinity of MSI-associated frameshift peptide neoantigens

New Targets and New Leads
Paola Bonaventura
Cancer Research Center of Lyon
Abstract #66
Identification of shared tumor epitopes from endogenous retroviruses inducing high avidity cytotoxic T cells for cancer immunotherapy

Immunomonitoring
Marie Christine Viuff
Technical University of Denmark
Abstract #164
Mapping of HPV-specific CD8+ T cells and immune signatures in cervical intraepithelial neoplasia and cancer


Tumor Biology & Interaction with the Immune System
Francesca Simoncello
International Centre for Genetic Engineering and Biotechnology
Abstract #196

Watch the presentation:
CXCL5-mediated accumulation of SiglecFhigh neutrophils in lung tumor tissues impairs CD8 T cell responses and limits the efficacy of PD-L1 checkpoint blockade

Improving Immunity
Miro Raeber
University Hospital Zurich
Abstract #75

Watch the presentation:
Interleukin-2 signals converge in a lymphoid–dendritic cell pathway that promotes anticancer immunity

Audience Choice
Valentina Volpin
Regensburg Center for Interventional Immunology (RCI)
Abstract #56

Watch the presentation:
The serine/threonine kinase CAMK1D confers immune resistance of PD-L1 refractory tumor cells against tumor-reactive cytotoxic T cells

CIMT 2019 Poster Awards

Each year, as part of the Annual Meeting, CIMT honors outstanding poster presentations of junior researchers with the CIMT Poster Awards

In 2019, the CIMT poster jury selected six young investigators for the quality of their research as well as their visual and oral data presentation. The poster awards prizes were supported by Immatics.

Tumor Biology & Interaction with the Immune System
Ehsan Ghorani, UCL Cancer Institute London
Abstract #144

"Imbalance between early and late differentiated intra-tumour CD4 T cells is associated with mutational burden and regulatory T cell abundance in non-small cell lung cancer"

Improving Immunity
Su Yin Lim, Macquarie University Sydney
Abstract #238

"Dynamic changes in transcriptome and cytokine expression in melanoma patients treated with combination PD-1 and CTLA-4 inhibitors"

Immunomonitoring
Juliane Schuhmacher, University of Tübingen
Abstract #070

“RhoC vaccination induces a robust and long-lasting immune response in a clinical phase I/II prostate cancer trial”

Cellular Therapy
Anna Müller-Schöll, Freie Universität Berlin
Abstract #100

“CAR-T cell therapy: Investigating clinical challenges using a modelling & simulation framework“

New Targets and New Leads
Hannah Wurzer, Luxembourg Institute of Health
Abstract #231

“The great escape: role of the actin cytoskeleton in cancer immune evasion”

Therapeutic Vaccination
Thomas Rösler,TRON-Translational Oncology Mainz
Abstract #037

”Modeling immunogenicity with omics data integration”

CIMT 2018 Poster Awards

Tumor Biology
Christof Smith, University of North Carolina at Chapel Hill
Abstract #110

"Pan-cancer analysis of human endogenous retrovirus expression reveals markers for prognosis and immunotherapy response in clear cell renal carcinoma"

Therapeutic Vaccination
Adam Grippin, University of Florida
Abstract #011

”Bifunctional RNA-nanoparticles to enhance dendriti cell activation and enable MRI-based detection of dendritic cell migration to lymph nodes”

Improving Immunity
Daniel Baumann, German Cancer Research Center DKFZ
Abstract #175

"Mouse models of pancreatic cancer for development of combinatorial immunotherapies involving cytostatic agents and agonist anti-CD40 antibody"

Immunomonitoring
Jonas Bochem, University Medical Center Tübingen
Abstract #034

“Peripheral blood NKT-cell frequencies and their PD-1 expression levels identify stage IV melanoma patients with poor overall survival under PD-1/CTLA-4 blockade”

Cellular Therapy
Julien Schmidt, University of Lausanne
Abstract #159

“TCR-pMHC 2D affinity and bond lifetime under force correlate with tumor-specific CD8 T cell responsiveness“

New Targets and New Leads
Chloe Chong, Ludwig Center for Cancer Research
Abstract #207

“Mass spectrometry-based antigen discovery expands the cancerimmunopeptidome”